文献速递前列腺增生与排尿功能障碍

宾夕法尼亚州仿制良性前列腺增生药物现金价格差异研究

Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications.
PubMed 文献 · Urology · 2020-09-19

该研究对宾夕法尼亚州20%随机药房抽样,询问无保险患者30天仿制BPH药物(坦索罗辛、非那雄胺、奥昔布宁速释/缓释)的现金价格,共联系575家药房、473家回应(82%)。结果显示大型连锁药房的中位现金价格显著高于独立药房,但独立药房的地区间价格变异更大。

要点

  • 大型连锁药房仿制BPH药物现金价格显著高于独立药房。
  • 独立药房在不同地区间的价格差异更大。
  • 控制药房类型后,四种药物第75百分位价格均存在地区差异。

核心结论

  • 大型连锁药房向无保险患者收取的仿制BPH药物现金价格显著高于独立药房。
  • 独立药房的价格在地区间变异更大。

研究设计与样本

  • 对宾夕法尼亚州20%随机药房抽样,询问无保险患者30天仿制BPH药物现金价格。
  • 共联系575家零售药房,473家回应(82%回应率)。
  • 采用多变量分位数回归模型控制药房类型后检验价格与地区的关联。

主要发现

  • 大型连锁药房的中位现金价格显著高于独立药房:坦索罗辛0.4mg每日(66美元 vs 15美元)、非那雄胺5mg每日(68美元 vs 15美元)、奥昔布宁速释5mg每日三次(49美元 vs 35美元)、奥昔布宁缓释10mg每日(79美元 vs 31美元),所有p<0.05。
  • 控制地区后,大型连锁药房所有药物的中位价格和第75百分位价格均显著更高。
  • 控制药房类型后,所有四种药物在第75百分位价格上均存在地区差异,且独立药房的地区差异更大。

临床怎么用

  • 临床医生在为无保险或保险不足的BPH患者选择仿制药物时,可考虑告知患者不同药房类型的价格差异。

局限性

  • 研究仅限宾夕法尼亚州,结论外推需谨慎。
  • 仅评估了现金价格,未涉及保险覆盖后的自付费用。
  • 未报告药物疗效或患者依从性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the geographic and pharmacy-type variation in costs for generic benign prostatic hyperplasia (BPH) medications in order to improve drug price transparency and reduce health disparities. Medical therapy for BPH can be expensive, having significant implications for uninsured and underinsured patients. METHODS: We generated a 20% random sample of all pharmacies in Pennsylvania and queried each for the uninsured cash price of a 30-day prescription of tamsulosin 0.4mg daily, finasteride 5mg daily, oxybutynin immediate release 5mg TID and oxybutynin XL 10mg daily. Our primary objectives were to identify price variation based on pharmacy type (i.e., big chain and independent) and between geographic regions (predetermined by the Pennsylvania Health Care Cost Containment Council Database). We fit multivariable quantile regression models to test for an association between drug price and region after controlling for pharmacy type. RESULTS: Among 575 retail pharmacies contacted, 473 responded (82% response rate). The median cash price was significantly higher for big chain pharmacies than for independent pharmacies for tamsulosin ($66 vs. $15), finasteride ($68 vs. $15), oxybutynin immediate release ($49 vs. $35), and oxybutynin XL ($79 vs. $31) (all p < 0.05). When controlling for region, the median and 75th percentile price of all drugs was significantly higher for big chain pharmacies. When controlling for pharmacy type, regional variation was noted in all four drugs at the 75th percentile price and was greater for independent pharmacies. CONCLUSION: Compared to independent pharmacies, big chain pharmacies charged significantly more for generic BPH medications to uninsured patients. However, independent pharmacies demonstrated more regional variation in their pricing.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Shah AA, Kumar P, Ogunmola AG, et al. Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications. Urology. 2020. PMID: 32961225. doi:10.1016/j.urology.2020.08.054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。